Jasper Therapeutics
Stock Forecast, Prediction & Price Target

Jasper Therapeutics (JSPR) stock Price Target by analysts

Last Year
Average Price Target

$63

Potential upside: 2134.04%

Based on 1 analysts

Jasper Therapeutics price prediction

Strike.market

What is Jasper Therapeutics stock analysts` prediction?

Jasper Therapeutics stock forecast: Based on 1 Wall Street analysts` predicted price targets for Jasper Therapeutics in the last 3 months, the avarage price target is $63, with a high forecast of $NaN. The average price target represents a 2134.04% change from the last price of $2.82.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Jasper Therapeutics stock Price Target by analysts

Full breakdown of analysts given Jasper Therapeutics price targets

Analyst name & company
Analyst win rate
Publish date
 Price target
Price when posted
 Source Historical targets
Etzer Darout
BMO Capital
0%
0/1
 10 months ago $63 2134.04% upside $21.53 StreetInsider
Previous targets (0)
Emily Bodnar
H.C. Wainwright
0%
0/1
 over 1 year ago $65 2204.96% upside $24.52 StreetInsider
Previous targets (0)
Gavin Clark-Gartner
Evercore ISI
0%
0/1
 over 1 year ago $65 2204.96% upside $26.2 StreetInsider
Previous targets (0)
Unknown
Cantor Fitzgerald
N/A
 over 2 years ago $6 112.76% upside $1.92 Benzinga
N/A
Unknown
Credit Suisse
N/A
 over 2 years ago $3 6.38% upside $1.65 Benzinga
N/A

Jasper Therapeutics Financial Estimates

Jasper Therapeutics Revenue Estimates

Jasper Therapeutics EBITDA Estimates

Jasper Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $4.88M
Low: $4.88M
High: $4.88M
avg. 0%
Avg: $1.58M
Low: $1.58M
High: $1.58M
avg. -67.63%
Avg: $24.21M
Low: $24.21M
High: $24.21M
avg. 1429.89%
Avg: $88.77M
Low: $88.77M
High: $88.77M
avg. 266.66%
Net Income
 
% change YoY
$-23.98M
 
N/A
$-24.17M
 
-0.79%
$-64.46M
 
-166.67%
Avg: $-78.66M
Low: $-53.03M
High: $-25.47M
avg. -22.02%
Avg: $-101.06M
Low: $-63.99M
High: $-39.25M
avg. -28.47%
Avg: $-45.92M
Low: $-45.92M
High: $-45.92M
avg. 54.55%
Avg: $-26.67M
Low: $-26.67M
High: $-26.67M
avg. 41.92%
EBITDA
 
% change YoY
$-43.10M
 
N/A
$-64.12M
 
-48.74%
$-64.98M
 
-1.34%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$21.05
 
N/A
-$6.63
 
68.50%
-$6.18
 
6.78%
Avg: -$4.21
Low: -$5.08
High: -$2.44
avg. 31.84%
Avg: -$4.97
Low: -$6.13
High: -$3.76
avg. -17.95%
Avg: -$4.4
Low: -$4.4
High: -$4.4
avg. 11.44%
Avg: -$2.56
Low: -$2.56
High: -$2.56
avg. 41.92%
Operating Expenses
 
% change YoY
$36.83M
 
N/A
$51.19M
 
38.99%
$68.86M
 
34.50%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Jasper Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 11.49% in 2025-2028.

We have gathered data from 8 analysts. Their low estimate is -53.03M, average is -78.66M and high is -25.47M.

What is Jasper Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 407.23% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is $4.88M, average is $4.88M and high is $4.88M.

What is Jasper Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 16.81% in 2025-2028.

We have gathered data from 8 analysts. Their low earnings per share estimate is -$5.08, average is -$4.21 and high is $-2.44.

What is the best performing analyst?

In the last twelve months 1 analysts have been covering Jasper Therapeutics stock. The most successful analyst is Etzer Darout.